Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03122405 · ClinicalTrials.gov registry record · NA

Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor

A NA study, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT03122405: Completed NA study, sponsored by Masimo Corporation.

NCT03122405 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03122405, a NA study, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this study was to conduct a side by side comparison of the accuracy of respiratory rate (RR) between our investigational Rainbow Acoustic Monitoring (RAM) small sensor and the FDA-cleared RAM Revision D sensor in healthy volunteers under controlled conditions.

Primary Outcome

Performance comparison was determined by comparing the noninvasive respiration rate measurement of the RAM sensors and calculating the arithmetic root mean square (Arms) error value.

Interventions

  • DEVICE RAM sensors

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-12-02
Est. Completion 2015-10-29
Phase NA
Masimo Corporation

96 total trials

What the finished NCT03122405 record still lists

NCT03122405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which RAM sensors is the first listed.

NCT03122405 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03122405 about?

NCT03122405 is a clinical study titled "Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor". The purpose of this study was to conduct a side by side comparison of the accuracy of respiratory rate (RR) between our investigational Rainbow Acoustic Monitoring (RAM) small sensor and the FDA-cleared RAM Revision D sensor in healthy volunteers under controlled conditions.

What is the current status of trial NCT03122405?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2014-12-02. Estimated completion is 2015-10-29.

What interventions are being tested in trial NCT03122405?

The interventions under investigation include: RAM sensors (DEVICE).

Who is sponsoring clinical trial NCT03122405?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03122405's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03122405, the US trial registry maintained by the National Library of Medicine. NCT03122405 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.